Organ cross-sensitization mechanisms in chronic diseases related to the genitourinary tract-Reference-Cited by-同舟云学术

Organ cross-sensitization mechanisms in chronic diseases related to the genitourinary tract

Published:2021 Issue:0 Volume:57 Page:49-52
ISSN:0916-8737
Container-title:Journal of Smooth Muscle Research
language:en
Short-container-title:J. Smooth Muscle Res.

Author:

Majima Tsuyoshi¹,Sassa Naoto¹

Affiliation:

1. Department of Urology, Aichi Medical University, 1-1 Yazakokarimata, Nagakute City, Aichi 480-1195, Japan

Publisher

Japan Society of Smooth Muscle Research

Subject

General Medicine,Physiology

Link

https://www.jstage.jst.go.jp/article/jsmr/57/0/57_0513/_pdf

Reference17 articles.

1. 1. Clemens, J.Q., Brown, S.O., Kozloff, L, Calhoun, E.A. Predictors of symptom severity in patients with chronic prostatitis and interstitial cystitis. J Urol. 2006; 175(3 Pt 1): 963–6 discussion 967.

2. 2. Fariello, J.Y., Moldwin, R.M. Similarities between interstitial cystitis/bladder pain syndrome and vulvodynia: implications for patient management. Transl Androl Urol. 2015; 4(6): 643–52.

3. 3. Pezzone, M.A., Liang, R, Fraser, M.O. A model of neural cross-talk and irritation in the pelvis: implications for the overlap of chronic pelvic pain disorders. Gastroenterology. 2005; 128(7): 1953–64.

4. 4. Malykhina, A.P. Neural mechanisms of pelvic organ cross-sensitization. Neuroscience. 2007; 149(3): 660–72.

5. 5. Birder, L.A. Pathophysiology of interstitial cystitis. Int J Urol. 2019; 26(Suppl 1): 12–5.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intravesical Botulinum Toxin Injection Plus Hydrodistention Is More Effective in Patients with Bladder Pain-Predominant Interstitial Cystitis/Bladder Pain Syndrome;Toxins;2024-02-01

2. Multimodal therapies and strategies for the treatment of interstitial cystitis/bladder pain syndrome in Taiwan;LUTS: Lower Urinary Tract Symptoms;2023-11-21

3. Predictors of chronic pelvic pain in female population;Russian Journal of Pain;2023

4. Biomarkers in the Light of the Etiopathology of IC/BPS;Diagnostics;2021-11-29